Release Date: 16/07/14 13:04 Summary: Ceasing to be a substantial holder Price Sensitive: No Download Document 86.29KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%